Auranofin as a Novel Anticancer Drug for Anaplastic Thyroid Cancer
<b>Background/Objectives:</b> Anaplastic thyroid cancer (ATC) is an aggressive and rare cancer with a poor prognosis, and traditional therapies have limited efficacy. This study investigates drug repositioning, focusing on auranofin, a gold-based drug originally used for rheumatoid arthr...
Saved in:
Main Authors: | Seung-Chan An (Author), Hak Hoon Jun (Author), Kyeong Mi Kim (Author), Issac Kim (Author), Sujin Choi (Author), Hyunjeong Yeo (Author), Soonchul Lee (Author), Hyun-Ju An (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum
by: James P. Solomon, et al.
Published: (2015) -
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
by: Jixuan Liu, et al.
Published: (2020) -
Metastatic Papillary Thyroid Carcinoma with Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma
by: Mark Benedict, et al.
Published: (2016) -
Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer
by: Sasan Fazeli MD, et al.
Published: (2019) -
Anaplastic carcinoma of the thyroid - clinicomorphological spectrum and review of literature
by: A Ghosh, et al.
Published: (2011)